-
WHO Sounds Alarm on Chikungunya Fever as Foshan’s Outbreak Surges
In a concerning development, the World Health Organization (WHO) has sounded the alarm on chikungunya fever, a mosquito-borne disease, as the situation in Foshan, China, continues to escalate. As of July 23, 2025, Foshan has reported over 3,000 confirmed cases of chikungunya fever, all of which a...Read more -
Chikungunya Outbreak: Navigating Symptom Overlaps, Global Travel Risks, and Diagnostic Solutions
1. The 2025 Shunde Outbreak: A Wake-Up Call for Travel Health In July 2025, Shunde District, Foshan, became the epicenter of a localized Chikungunya outbreak triggered by an overseas imported case. By July 15, just one week after the first confirmed infection, 478 mild cases had been reported—hi...Read more -
Testsealabs and Strategic Partner Join Hands with Nobel Laureate to Write a New Chapter in Cell and Gene Therapy
Recently, Mr. Zhou Bin, General Manager of Testsealabs, was invited to attend the contract renewal ceremony between strategic partner Hailiang Biotechnology Co., Ltd. and Professor Randy Schekman, Nobel Laureate in Physiology or Medicine and member of the US National Academy of Sciences. This ren...Read more -
Testsealabs Set to Shine at Asia Health Medlab Asia 2025
Hangzhou Testsea Biotechnology Co., Ltd., renowned as Testsealabs, is thrilled to announce its participation in the highly anticipated Asia Health Medlab Asia, a premier event in the medical laboratory industry. The exhibition will take place from July 16th to 18th, 2025, in Malaysia, and...Read more -
International Clients Explore Testsealabs: Showcasing Excellence in Biotechnology
In a significant display of international collaboration and business growth, Hangzhou Testsea Biotechnology Co., Ltd., known as Testsealabs, recently hosted clients from Ukraine and Somalia. The visit provided an in – depth look into the company’s operations, highlighting its cutting ...Read more -
Testsealabs Pioneers Women’s Health with Advanced Diagnostic Products
In the ever – evolving landscape of women’s health, Testsealabs stands at the forefront as a dedicated innovator, committed to developing cutting – edge solutions that prioritize women’s well – being. With a deep understanding of the challenges women face in maintai...Read more -
Innovation in Colloidal Gold Technology: From “Single” to “Multi-Linked” to “One-Hole Precision”
Breakthroughs in multi-component testing technology have significantly enhanced clinical efficiency by transforming the way healthcare teams diagnose and manage diseases. These advances enable doctors to detect multiple health markers simultaneously, leading to faster and more accurate results. ...Read more -
Testsealabs Rises to the Challenge Amid Thailand’s COVID-19 Resurgence
In Thailand, the relaxation of border controls and epidemic prevention measures, coupled with a decline in public immunity, has triggered a concerning resurgence of the COVID-19 pandemic. The Thai Ministry of Public Health is closely monitoring the XEC variant of the coronavirus, which exhibits ...Read more -
How Rapid Detection of Respiratory Diseases Saves Lives
Introduction In a world where respiratory diseases pose a significant threat to global health, accounting for 20% of global mortality according to WHO data, Hangzhou Testsea Biotechnology Co., Ltd. is at the forefront of developing innovative at-home diagnostics that empower individuals to take ...Read more -
Testsealabs and hailiangbio have reached a strategic cooperation to integrate their technical channels and jointly explore new global markets
On May 14, 2025, Hangzhou Testsea Biotechnology Co., Ltd.(hereinafter referred to as ” Testsealabs”) and Zhejiang hailiangbio Co., Ltd. (hereinafter referred to as “hailiangbio”) officially entered into a strategic cooperation agreement. The collaboration aims to accelerat...Read more -
Discover the Fastest Solution for Respiratory Disease Detection
Scientific Approaches to Respiratory Pathogen Differentiation and Advanced Diagnostic Technologies With climate change and pathogen diversification, the high incidence of respiratory diseases has become the norm. Influenza, COVID-19, mycoplasma infections, and other illnesses often lead to publi...Read more -
Iran’s state television focuses on the localization practices of Hangzhou Testsea Biotechnology Co., Ltd.
In April 2024,Hangzhou Testsea Biotechnology Co., Ltd. underwent its first in-depth interview with the Asia and Africa Center of China Media Group and Iran’s National Television. As a national high-tech enterprise nurtured by Yuhang District of Hangzhou City, Taixi Biotech has showcased its...Read more
